C. Kent Osborne
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Co-authors
- Suzanne A.W. Fuqua (9 shared papers)Rachel Schiff (26 shared papers)William McGuire (5 shared papers)Gary M. Clark (5 shared papers)G M Clark (1 shared paper)Kim Hobbs (1 shared paper)Susan G. Hilsenbeck (13 shared papers)Hong Zhao (1 shared paper)
- Journals
- Journal of Clinical Oncology (25 papers)Cancer Research (17 papers)Breast Cancer Research and Treatment (14 papers)Cancer (5 papers)Blood (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
C. Kent Osborne
104 papers receiving 7.5k citations
C. Kent Osborne's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 2.2k
- Oncology 3.3k
- Genetics 2.8k
- Pathology and Forensic Medicine 916
- Molecular Biology 2.7k
Countries citing papers authored by C. Kent Osborne
This map shows the geographic impact of C. Kent Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kent Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kent Osborne more than expected).
Fields of papers citing papers by C. Kent Osborne
This network shows the impact of papers produced by C. Kent Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kent Osborne. The network helps show where C. Kent Osborne may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Kent Osborne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu Hit paper breakdown → | 1992 | 648 |
| 2 | Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes Hit paper breakdown → | 1998 | 582 |
| 3 | Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. | 1985 | 364 |
| 4 | 1998 | 361 | |
| 5 | 1984 | 326 | |
| 6 | 1995 | 309 | |
| 7 | 2000 | 294 | |
| 8 | 2015 | 292 | |
| 9 | 1989 | 291 | |
| 10 | Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. | 1995 | 270 |
| 11 | 2003 | 255 | |
| 12 | 1982 | 207 | |
| 13 | 2010 | 185 | |
| 14 | 2009 | 184 | |
| 15 | 2005 | 162 | |
| 16 | 2001 | 145 | |
| 17 | Estrogen receptor: current understanding of its activation and modulation. | 2001 | 141 |
| 18 | 1983 | 128 | |
| 19 | 2005 | 119 | |
| 20 | 2003 | 116 |
About C. Kent Osborne
C. Kent Osborne is a scholar working on Oncology, Genetics, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 109 papers that have together received 7.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (34 papers), Breast Cancer Treatment Studies (26 papers), HER2/EGFR in Cancer Research (24 papers), Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (3.3k citations), Genetics (2.8k citations), Pathology and Forensic Medicine (916 citations) and Molecular Biology (2.7k citations). C. Kent Osborne has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Suzanne A.W. Fuqua, Rachel Schiff, William McGuire, Gary M. Clark, G M Clark, Kim Hobbs, Susan G. Hilsenbeck, Hong Zhao, Christopher C. Benz and Jay Sarup. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.